Related Experiment Video
Updated: Jun 13, 2026

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Comparison of salivary caspase-3 biomarker in peri-implantitis among type 2 diabetic patients
Madhu Kiran1, Awadesh Kumar Gupta2, Deepak Bala3
1Department of Conservative Dentistry and Endodontics, Sri Venkateswara Dental College, Bannerghatta, Bengaluru, Karnataka, India.
Abstract:
Diagnostic biomarker-based methodologies have become the form of reliable non-invasive measures of diagnosis of peri-implant disorders at the earliest possible stage. Therefore, it is of interest to determine efficacy of salivary caspase-3 levels as a non-invasive biomarker of early peri-implantitis (PI) diagnosis in diabetic patients with type 2 diabetes. The number of participants was 36, which was separated into three groups. Group I- PI with the presence of the diabetes mellitus (DM + PI) and group II- PI without the diabetes mellitus (NDM + PI) and group III- periodontally healthy and no diabetes mellitus (NDM + PH). Each of the participants had unstimulated whole saliva (10 mL) collected. Centrifugation and Salivary caspase-3 levels quantification was done on samples by using a commercially available Human Caspase-3 enzyme-linked immunosorbent assay kit. The data obtained was statistically tested. Caspase-3 has the potential of being a non- invasive salivary biomarker in high-risk groups.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes III: Clinical Manifestations